On May 13th, DINGDANG HEALTH (09886) spent 2.9257 million Hong Kong dollars to repurchase 2.887 million shares.
Dingdang Health (09886) announced that the company repurchased 2.887 million shares for 2.9257 million Hong Kong dollars on May 13, 2026, at a repurchase price of 0.95-1.03 Hong Kong dollars per share.
DINGDANG HEALTH (09886) announces that the company repurchased 2.887 million shares at a total cost of HKD 2.9257 million on May 13, 2026, at a repurchase price of HKD 0.95-1.03 per share.
Related Articles
OCT (ASIA) is planning to publicly list and sell 100% equity of Overseas Chinese Town (Huizhou).
Wellington Management Group LLP has reduced its holdings in Weichai Power (02338) by approximately 5.0998 million shares, with a price per share of around 41.57 Hong Kong dollars.
UBS increases its holding in Jl Mag Rare-Earth (06680) by 25.34 thousand shares, with a price of approximately HKD 19.92 per share.
OCT (ASIA) is planning to publicly list and sell 100% equity of Overseas Chinese Town (Huizhou).
Wellington Management Group LLP has reduced its holdings in Weichai Power (02338) by approximately 5.0998 million shares, with a price per share of around 41.57 Hong Kong dollars.
UBS increases its holding in Jl Mag Rare-Earth (06680) by 25.34 thousand shares, with a price of approximately HKD 19.92 per share.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
